Whalesbook
Bain Capital's Offer Details
Manappuram Finance shares jumped sharply on March 25, 2026, after Bain Capital announced an open offer to buy up to 26% of the company's public shares. The offer price is ₹236 per share, plus ₹12.29 per share for interest due to a transaction delay. The offer period is set from April 6 to April 20, 2026. This is part of Bain Capital's acquisition plan, which aims for completion by March 31, 2026. The deal involves about ₹4,385 crore and has received key approvals, including from the Reserve Bank of India, allowing Bain Capital to share joint control with current promoters. Manappuram Finance stock rose 4.47%, beating the BSE Sensex's 2.32% gain.
Valuation vs. Financial Performance
Despite the rally fueled by the acquisition, Manappuram Finance's valuation appears high compared to its recent financial performance and rivals. As of March 24, 2026, its P/E ratio was around 55.56, significantly higher than Muthoot Finance (P/E ~14-17) and Cholamandalam Investment and Finance (P/E ~24-29). This high valuation contrasts with its Q3 FY26 results, which showed net profit fell about 61.47% year-on-year to ₹219.88 crore from ₹570.65 crore. Net interest income also dropped 18.36% year-on-year to ₹1,298.9 crore. Operating margins shrunk to 9.52% in Q3 FY26 from 21.73% a year ago. While gold loan Assets Under Management (AUM) grew strongly by 58.2% year-on-year, this growth is not fully translating into profits due to issues in other areas. The broader NBFC sector expects 15-17% AUM growth in FY26, with gold loans performing well due to lender caution elsewhere and rising gold prices. However, Manappuram's key figures suggest it's struggling to turn its revenue growth into actual profit.
Analyst Concerns and Price Targets
Manappuram Finance's P/E ratio of over 55-60 also seems out of step with its operational performance and how rivals are valued. Its Return on Equity (ROE) is much lower at 3.26% or 10.1%, versus Muthoot Finance's 27.21% and Cholamandalam's 17.91%-19.72%. A major factor hurting profits is its microfinance unit, Asirvad Microfinance, which lost ₹156 crore in Q3 FY26. The company's standalone net profit fell 16% year-on-year, partly due to a 19% rise in expenses and higher impairment costs. At a market price of ₹262.85 on March 25, 2026, the stock could face downward pressure. One analyst forecast suggests a potential drop to ₹209.19-₹246.96 within three months. Analyst reports also indicate earnings per share (EPS) missed forecasts by 29%, leading to revised estimates. The stock's short and long-term moving averages show negative trends, suggesting a cautious view.
Outlook and Brokerage Views
Analysts generally hold a cautious view, with a consensus 'Hold' recommendation for Manappuram Finance. Average price targets range from ₹259.20 to ₹306.07. This suggests limited upside from recent trading prices and offers little premium over the ₹236 offer price. Projections show strong future earnings and revenue growth (e.g., 63.9% annual earnings growth), but this relies on improving profitability and Bain Capital's strategy integration. Jefferies maintains a 'Hold' with a ₹285 target, expecting slight EPS dilution and book value gains from the new capital, pending a clear strategy from new management. Morgan Stanley rates the stock 'Equal Weight' with a ₹315 target, seeing the deal's completion as a possible short-term positive for sentiment.